dc.contributor.author |
Borst, Oliver |
|
dc.contributor.author |
Gawaz, Meinrad Paul |
|
dc.date.accessioned |
2021-09-20T08:57:53Z |
|
dc.date.available |
2021-09-20T08:57:53Z |
|
dc.date.issued |
2021 |
|
dc.identifier.issn |
0163-7258 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/119073 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Pergamon - Elsevier Science Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.pharmthera.2020.107630 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Glycoprotein VI - novel target in antiplatelet medication |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20210512015105_01503 |
|
utue.personen.roh |
Borst, Oliver |
|
utue.personen.roh |
Gawaz, Meinrad |
|
dcterms.isPartOf.ZSTitelID |
Pharmacology & Therapeutics |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 107630 |
de_DE |
dcterms.isPartOf.ZS-Volume |
217 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |